- Home
- CCEL vs SPAI Comparison
CCEL vs SPAI Comparison
Compare CCEL & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- SPAI
- Stock Information
- Founded
- CCEL 1989
- SPAI 2021
- Country
- CCEL United States
- SPAI United States
- Employees
- CCEL N/A
- SPAI N/A
- Industry
- CCEL Managed Health Care
- SPAI Industrial Specialties
- Sector
- CCEL Health Care
- SPAI Health Care
- Exchange
- CCEL Nasdaq
- SPAI Nasdaq
- Market Cap
- CCEL 39.9M
- SPAI 38.5M
- IPO Year
- CCEL 1997
- SPAI 2024
- Fundamental
- Price
- CCEL $4.90
- SPAI $4.14
- Analyst Decision
- CCEL Strong Buy
- SPAI Strong Buy
- Analyst Count
- CCEL 1
- SPAI 1
- Target Price
- CCEL $8.50
- SPAI $8.00
- AVG Volume (30 Days)
- CCEL 7.1K
- SPAI 320.2K
- Earning Date
- CCEL 07-15-2025
- SPAI 09-25-2025
- Dividend Yield
- CCEL 12.50%
- SPAI N/A
- EPS Growth
- CCEL N/A
- SPAI N/A
- EPS
- CCEL N/A
- SPAI N/A
- Revenue
- CCEL $31,988,783.00
- SPAI $2,046,327.00
- Revenue This Year
- CCEL $1.75
- SPAI N/A
- Revenue Next Year
- CCEL N/A
- SPAI N/A
- P/E Ratio
- CCEL N/A
- SPAI N/A
- Revenue Growth
- CCEL 1.10
- SPAI 140.22
- 52 Week Low
- CCEL $4.68
- SPAI $1.47
- 52 Week High
- CCEL $9.43
- SPAI $6.50
- Technical
- Relative Strength Index (RSI)
- CCEL 48.00
- SPAI N/A
- Support Level
- CCEL $4.75
- SPAI N/A
- Resistance Level
- CCEL $5.43
- SPAI N/A
- Average True Range (ATR)
- CCEL 0.26
- SPAI 0.00
- MACD
- CCEL 0.01
- SPAI 0.00
- Stochastic Oscillator
- CCEL 28.38
- SPAI 0.00
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.